Niagen Bioscience (NASDAQ:NAGE) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 127.27 percent. This is a 44.44 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $33.839 million which beat the analyst consensus estimate of $31.705 million by 6.73 percent. This is a 16.19 percent increase over sales of $29.125 million the same period last year.